ALN-5288

· Alnylam Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-5288, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease [Phase 1]